Search

Your search keyword '"Shibutani, Masatsune"' showing total 487 results
Start Over Author "Shibutani, Masatsune"
487 results on '"Shibutani, Masatsune"'

14. Prognostic significance of connective tissue growth factor expression in stromal cells in patients with diffuse‑type gastric cancer

Author

Miki, Yuichiro, primary, Yoshii, Mami, additional, Miyauchi, Ryoko, additional, Kasashima, Hiroaki, additional, Fukuoka, Tatsunari, additional, Tamura, Tatsuro, additional, Shibutani, Masatsune, additional, Toyokawa, Takahiro, additional, Lee, Shigeru, additional, Yashiro, Masakazu, additional, and Maeda, Kiyoshi, additional

Published
2024
Full Text
View/download PDF

20. Correlation between postoperative systemic inflammatory response and prognosis in patients with advanced gastric cancer.

Author

Kuroda, Kenji, primary, Toyokawa, Takahiro, additional, Miki, Yuichiro, additional, Yoshii, Mami, additional, Kasashima, Hiroaki, additional, Fukuoka, Tatsunari, additional, Tamura, Tatsuro, additional, Shibutani, Masatsune, additional, Lee, Shigeru, additional, Yashiro, Masakazu, additional, and Maeda, Kiyoshi, additional

Published
2024
Full Text
View/download PDF

22. Optimal extent of lymph node dissection for high‐risk gastric cancer stratified by a national clinical database risk calculator.

Author

Kuroda, Kenji, Miki, Yuichiro, Kasashima, Hiroaki, Yoshii, Mami, Fukuoka, Tatsunari, Tamura, Tatsuro, Shibutani, Masatsune, Toyokawa, Takahiro, Lee, Shigeru, and Maeda, Kiyoshi

Subjects
LYMPHADENECTOMY, STOMACH cancer, DATABASES, GASTRECTOMY, PANCREATIC fistula, PANCREATECTOMY
Abstract

Background: For patients with gastric cancer, a well‐balanced treatment that considers both oncological aspects and surgical risk is demanded. This study aimed to explore the optimal extent of lymph node dissection (LND) for patients with gastric cancer according to surgical risk, stratified by the risk calculator system produced by the Japan National Clinical Database (NCD). Patients and Methods: We retrospectively evaluated 187 patients who underwent radical gastrectomy for gastric cancer. Using the median predicted anastomotic leak rate obtained by the NCD risk calculator as the cutoff value, we classified 97 and 90 patients as having high and low risks, respectively. Results: In low‐risk patients, although limited LND reduced the postoperative intraabdominal infectious complications (IAIC), multivariate analysis revealed standard LND as an independent prognostic factor that improved Relapse‐free survival (RFS). In high‐risk patients, the rates of postoperative IAIC and RFS were similar between standard and limited LND. Pancreatic fistula was not observed in the limited dissection group. Conclusion: Limited LND might be the optimal treatment strategy for patients with gastric cancer with high surgical risk. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

25. Usefulness of Biopsy Specimens for Evaluating CD103+Tumor-resident Memory T Cells in Esophageal Cancer

Author

NATSUKI, SEIJI, primary, MIKI, YUICHIRO, additional, TANAKA, HIROAKI, additional, NISHIYAMA, MASAKI, additional, KASASHIMA, HIROAKI, additional, FUKUOKA, TATSUNARI, additional, YOSHII, MAMI, additional, TAMURA, TATSURO, additional, SHIBUTANI, MASATSUNE, additional, TOYOKAWA, TAKAHIRO, additional, LEE, SHIGERU, additional, and MAEDA, KIYOSHI, additional

Published
2023
Full Text
View/download PDF

26. O4-3 An update analysis of the JACCRO CC-16: Ramucirumab plus FOLFIRI for RAS wild-type mCRC refractory to anti-EGFR antibody

Author

Manaka, Dai, primary, Tsuji, Akihito, additional, Shibutani, Masatsune, additional, Ishibashi, Keiichiro, additional, Yabuno, Taichi, additional, Okamura, Shu, additional, Furuya, Takumi, additional, Tanaka, Chihiro, additional, Nakamura, Masato, additional, Sagawa, Tamotsu, additional, Watanabe, Takanori, additional, Shiozawa, Manabu, additional, Sunakawa, Yu, additional, Ota, Hirofumi, additional, Kotaka, Masahito, additional, Okuyama, Hiroyuki, additional, Okita, Yoshihiro, additional, Cancer Research Organization, Japan Clinical, additional, Ichikawa, Wataru, additional, and Fujii, Masashi, additional

Published
2023
Full Text
View/download PDF

27. Prognostic Role of Preoperative D-dimer Levels in Patients With Stage I-III Colorectal Cancer

Author

SHIBUTANI, MASATSUNE, KASHIWAGI, SHINICHIRO, FUKUOKA, TATSUNARI, ISEKI, YASUHITO, KASASHIMA, HIROAKI, KITAYAMA, KISHU, and MAEDA, KIYOSHI

Subjects
Research Article
Abstract

Background/Aim: As D-dimer levels have been reported to reflect cancer activity, preoperative D-dimer levels may serve as a prognostic marker in patients with colorectal cancer. The aim of this study was to evaluate the prognostic significance of preoperative D-dimer levels in patients with stage I-III colorectal cancer who underwent curative surgery. Patients and Methods: A total of 264 patients who underwent curative surgery for stage I-III colorectal cancer between January 2015 and December 2019 were enrolled in this study. Results: The median preoperative D-dimer level was 0.8 μg/ml (range=0.4-42.5 μg/ml). Based on the results of a receiver operating characteristic curve analysis, we set 1.45 as the cut-off value and classified patients into the low (n=215) and high D-dimer (n=49) groups. The high D-dimer group had significantly lower relapse-free and overall survival in comparison to the low D-dimer group (p

Published
2022

34. Validation of the Optimum Timing of Assessment of Tumor Infiltrating Lymphocytes During Preoperative Chemotherapy for Breast Cancer

Author

KASHIWAGI, SHINICHIRO, ASANO, YUKA, TAKADA, KOJI, GOTO, WATARU, KOUHASHI, RIKA, YABUMOTO, AKIMICHI, TAUCHI, YUKIE, MORISAKI, TAMAMI, OGISAWA, KANA, SHIBUTANI, MASATSUNE, TANAKA, HIROAKI, and OHIRA, MASAICHI

Subjects
Research Article
Abstract

Background/Aim: Tumor microenvironment (TME) assessment is considered to play an important role in the prediction of prognosis and therapeutic response following breast cancer treatment. No consensus has been reached regarding evaluation methods despite reports on the utilization of tumor-infiltrating lymphocytes (TILs) for immune TME (iTME) monitoring. Optimum timing of iTME assessment has not yet been established. Patients and Methods: Two hundred thirty-nine patients were treated with neoadjuvant chemotherapy (NAC). During the period from diagnostic needle biopsy to NAC initiation for breast cancer, the optimal evaluation timing was examined using a receiver operating characteristic (ROC) curve analysis. Results: A significant correlation between TILs and pathological complete response (pCR) was only observed in the short-term group (≤35 days) (p=0.033). Prognostic analysis revealed that in the short-term group, patients with high TIL levels had a significantly better survival prognosis relative to those with low TIL levels (>35 days) [disease-free survival (DFS): p=0.001, overall survival (OS): p=0.021]. TILs were identified as an independent factor affecting DFS in a multivariate analysis (p=0.008, hazard ratio=0.130). Conclusion: TIL assessment during NAC for breast cancer is a prognostic predictor only when performed at ≤35 days before NAC initiation.

Published
2022

35. Eribulin Treatment Promotes Re-expression of Estrogen Receptor in Endocrine Therapy-resistant Hormone Receptor-positive Breast Cancer Cells

Author

GOTO, WATARU, primary, KASHIWAGI, SHINICHIRO, additional, IIMORI, NOZOMI, additional, KOUHASHI, RIKA, additional, YABUMOTO, AKIMICHI, additional, TAKADA, KOJI, additional, ASANO, YUKA, additional, TAUCHI, YUKIE, additional, OGISAWA, KANA, additional, MORISAKI, TAMAMI, additional, SHIBUTANI, MASATSUNE, additional, TANAKA, HIROAKI, additional, and MAEDA, KIYOSHI, additional

Published
2023
Full Text
View/download PDF

36. Prognostic Impact of Smoking on Bevacizumab Combination Chemotherapy for Advanced Breast Cancer

Author

TAKADA, KOJI, primary, KASHIWAGI, SHINICHIRO, additional, IIMORI, NOZOMI, additional, KOUHASHI, RIKA, additional, YABUMOTO, AKIMICHI, additional, GOTO, WATARU, additional, ASANO, YUKA, additional, TAUCHI, YUKIE, additional, OGISAWA, KANA, additional, MORISAKI, TAMAMI, additional, SHIBUTANI, MASATSUNE, additional, TANAKA, HIROAKI, additional, and MAEDA, KIYOSHI, additional

Published
2023
Full Text
View/download PDF

37. Assessment of the role of neutrophil-lymphocyte ratio as a prognostic biomarker in breast cancer patients: a cross-sectional study

Author

Takada, Koji, primary, Kashiwagi, Shinichiro, additional, Iimori, Nozomi, additional, Kouhashi, Rika, additional, Yabumoto, Akimichi, additional, Goto, Wataru, additional, Asano, Yuka, additional, Tauchi, Yukie, additional, Ogisawa, Kana, additional, Morisaki, Tamami, additional, Shibutani, Masatsune, additional, Tanaka, Hiroaki, additional, and Maeda, Kiyoshi, additional

Published
2023
Full Text
View/download PDF

41. Factor Analysis of Intraoperative Bleeding Loss and its Impact on Prognosis in Breast Cancer

Author

TAKADA, KOJI, primary, KASHIWAGI, SHINICHIRO, additional, IIMORI, NOZOMI, additional, KOUHASHI, RIKA, additional, YABUMOTO, AKIMICHI, additional, GOTO, WATARU, additional, ASANO, YUKA, additional, TAUCHI, YUKIE, additional, OGISAWA, KANA, additional, MORISAKI, TAMAMI, additional, SHIBUTANI, MASATSUNE, additional, TANAKA, HIROAKI, additional, and MAEDA, KIYOSHI, additional

Published
2022
Full Text
View/download PDF

45. Impact of oral statin therapy on clinical outcomes in patients with cT1 breast cancer

Author

Takada, Koji, primary, Kashiwagi, Shinichiro, additional, Iimori, Nozomi, additional, Kouhashi, Rika, additional, Yabumoto, Akimichi, additional, Goto, Wataru, additional, Asano, Yuka, additional, Tauchi, Yukie, additional, Morisaki, Tamami, additional, Ogisawa, Kana, additional, Shibutani, Masatsune, additional, Tanaka, Hiroaki, additional, and Maeda, Kiyoshi, additional

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results